Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,979.50    -3.50 (-0.18%)
Bid:
1,982.50
Ask:
1,983.50
Spread: 1.00 (0.05%)
Market Cap: £79.31b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Glaxosmithkline News

LONDON BROKER RATINGS: RBC ups Central Asia Metals to 'sector perform'
17 hours ago

LONDON BROKER RATINGS: RBC ups Central Asia Metals to 'sector perform'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

LONDON BRIEFING: BT, Verizon merge international arms in joint venture
19 hours ago

LONDON BRIEFING: BT, Verizon merge international arms in joint venture

(Alliance News) - BT and Verizon form international joint venture, Foresight increases its dividend while Plus500 adds to its US prediction markets of...

US military requires flu vaccine for some after outbreak in Texas training center
5 days ago

US military requires flu vaccine for some after outbreak in Texas training center

June 24 (Reuters) - The U.S. military has ​resumed ⁠requiring flu vaccines for some service ​members in an exception to Defense Secretary Pete Hegseth...

GSK launches tender offer for USD10.6 billion purchase of Nuvalent
5 days ago

GSK launches tender offer for USD10.6 billion purchase of Nuvalent

(Alliance News) - GSK PLC on Wednesday said it has launched the tender offer for its previously announced acquisition of US-based cancer drug develope...

IN BRIEF: GSK executives, including non-exec chair, buy shares
23 Jun 2026

IN BRIEF: GSK executives, including non-exec chair, buy shares

GSK PLC - London-based pharmaceuticals firm - Non-Executive Chair Jonathan Symonds buys 1,550 shares at GBP19.35 for total GBP29,992.50 last Friday. D...

Moderna's mRNA flu vaccine backed by FDA advisers
18 Jun 2026

Moderna's mRNA flu vaccine backed by FDA advisers

* ⁠FDA advisers back mFlusiva's benefits for adults 50 and up

GSK says US FDA approves urinary tract infection treatment Utebzi
17 Jun 2026

GSK says US FDA approves urinary tract infection treatment Utebzi

(Alliance News) - GSK PLC and Spero Therapeutics Inc on Wednesday said that the US Food & Drug Administration has approved Utebzi, an oral antibiotic ...

GSK drug momelotinib gains regulatory nods as VEXAS treatment
12 Jun 2026

GSK drug momelotinib gains regulatory nods as VEXAS treatment

(Alliance News) - GSK PLC on Friday announced that momelotinib has received orphan drug designation from the US Food & Drug Administration, and the Eu...